Hazardous Surgical Smoke: Risk Assessment and Evaluation of a New Smoke Extractor System in the Surgical Unit
1 other identifier
observational
142
1 country
1
Brief Summary
The investigators will define two separate groups of surgical procedures: 1.) an 'open group' in which mainly open anatomic lung resections will be included, and 2.) a 'minimally invasive' group in which mainly thoracoscopic anatomic lung resections will be included. Both groups will then be randomized to either the performance of the surgical procedure under 'standard conditions' or to the performance of the procedure with the additional use of a smoke evacuation system. During every procedure the hazardous smoke that is generated by the electrocautery in the surgical field will be collected through a tube at the height of the surgeons face. The smoke is then directly transferred to a mass spectrometer that is situated in the operating room (OR) and performs a real-time analysis of the chemical substances in the air. The degree of air pollution will be measured as well as the smoke evacuation systems' ability to reduce these hazardous chemical substances in the air can be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 9, 2019
CompletedFirst Posted
Study publicly available on registry
April 23, 2019
CompletedStudy Start
First participant enrolled
May 13, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 9, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 9, 2019
CompletedOctober 3, 2019
October 1, 2019
4 months
April 9, 2019
October 2, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hazardous fumes - specifically the concentration of Furfural, Benzene and Butadiene
Analysis of surgical fume with real-time time of flight mass spectrometry
assessment of measurement will start 4 months after the project is started and will take up to 12 weeks
Study Arms (4)
Minimally invasive surgery with smoke evacuation system (SES)
minimally invasive surgical procedures during which a smoke evacuation device is used
Minimally invasive surgery without SES
minimally invasive surgical procedures during which no smoke evacuation device is used
Open surgery with SES
open surgical procedures during which a smoke evacuation device is used
Open surgery without SES
open surgical procedures during which no smoke evacuation device is used
Interventions
The smoke evacuation system removes the surgical smoke directly near the electrocautery tip, where it is generated
Eligibility Criteria
All surgical procedures that will be performed during the study period at the investigators' department will be randomly allocated to either the performance of surgery with or the performance of surgery without the use of a mobile smoke evacuation device. Whether the procedure will be performed open or minimally invasive will be decided by the operating surgeon and is not part of the randomization process. During the respective surgeries, a mass spectrometer will be used to measure the smoke concentrations and its composition in the operating room.
You may qualify if:
- \- All surgical procedures with a planned duration of more than 1 hour
You may not qualify if:
- Patients with a contraindication for electrocautery use
- Patients with Pacemaker or implantable cardioverter-defibrillator (ICD)
- Patients with an implanted neurostimulator device
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Insel Gruppe AG, University Hospital Bernlead
- Tofwerk AG, Thun Switzerland (equipment, data analysis)collaborator
- Lungenliga Bern (main funding)collaborator
- Erbe Swiss AG (equipment)collaborator
Study Sites (1)
University Hospital Bern
Bern, 3010, Switzerland
Related Publications (2)
Kocher GJ, Sesia SB, Lopez-Hilfiker F, Schmid RA. Surgical smoke: still an underestimated health hazard in the operating theatre. Eur J Cardiothorac Surg. 2019 Apr 1;55(4):626-631. doi: 10.1093/ejcts/ezy356.
PMID: 30388210BACKGROUNDKocher GJ, Koss AR, Groessl M, Schefold JC, Luedi MM, Quapp C, Dorn P, Lutz J, Cappellin L, Hutterli M, Lopez-Hilfiker FD, Al-Hurani M, Sesia SB. Electrocautery smoke exposure and efficacy of smoke evacuation systems in minimally invasive and open surgery: a prospective randomized study. Sci Rep. 2022 Mar 23;12(1):4941. doi: 10.1038/s41598-022-08970-y.
PMID: 35322134DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gregor J Kocher, PD, MD
Division of Thoracic Surgery, University Hospital Bern, Switzerland
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 9, 2019
First Posted
April 23, 2019
Study Start
May 13, 2019
Primary Completion
September 9, 2019
Study Completion
September 9, 2019
Last Updated
October 3, 2019
Record last verified: 2019-10
Data Sharing
- IPD Sharing
- Will not share